Fulcrum Therapeutics Inc (NAS:FULC)
$ 7.47 -0.03 (-0.4%) Market Cap: 464.29 Mil Enterprise Value: 238.89 Mil PE Ratio: 0 PB Ratio: 1.97 GF Score: 48/100

Fulcrum Therapeutics Inc at Bank of America Biotech SMID Cap Conference Transcript

Dec 08, 2022 / 02:10PM GMT
Release Date Price: $6.14
Operator

Ladies and gentlemen, the program is about to begin. Reminder that you can submit questions at any time via the ask questions tab on the webcast page. At this time, it is my pleasure to turn the program over to your host, Tazeen Ahmad.

Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst

Great. Thanks, Joe. Good morning, everybody, and thanks for joining us again at the BofA Virtual SMID Biotech Conference. It's my pleasure to have our next presenting company, Fulcrum Therapeutics and presenting for Fulcrum for the next 30 minutes will be CEO, Bryan Stuart. Bryan, good morning. Thank you for joining us.

Bryan E. Stuart
Fulcrum Therapeutics, Inc. - President, CEO & Director

Yes. Good morning, Tazeen. Thanks for having us.

Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst

All right. So we only have 30 minutes together today. So I think there's a lot going on at the company. So I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot